Cargando…

Homogeneous surrogate virus neutralization assay to rapidly assess neutralization activity of anti-SARS-CoV-2 antibodies

The COVID-19 pandemic triggered the development of numerous diagnostic tools to monitor infection and to determine immune response. Although assays to measure binding antibodies against SARS-CoV-2 are widely available, more specific tests measuring neutralization activities of antibodies are immedia...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Sun Jin, Yao, Zhong, Marsh, Morgan C., Eckert, Debra M., Kay, Michael S., Lyakisheva, Anna, Pasic, Maria, Bansal, Aiyush, Birnboim, Chaim, Jha, Prabhat, Galipeau, Yannick, Langlois, Marc-André, Delgado, Julio C., Elgort, Marc G., Campbell, Robert A., Middleton, Elizabeth A., Stagljar, Igor, Owen, Shawn C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9249905/ https://www.ncbi.nlm.nih.gov/pubmed/35778399 http://dx.doi.org/10.1038/s41467-022-31300-9

Ejemplares similares

Predictors of self-reported symptoms and testing for COVID-19 in Canada using a nationally representative survey
por: Wu, Daphne C., et al.
Publicado: (2020)

Detection of SARS-CoV-2 Antibodies: Comparison of Enzyme Immunoassay, Surrogate Neutralization and Virus Neutralization Test
por: Vilibic-Cavlek, Tatjana, et al.
Publicado: (2023)

Immuno-Colorimetric Neutralization Test: A Surrogate for Widely Used Plaque Reduction Neutralization Tests in Public Health Virology
por: Vaidya, Sunil R.
Publicado: (2023)

Performance evaluation of newly developed surrogate virus neutralization tests for detecting neutralizing antibodies against SARS-CoV-2
por: Kweon, Oh Joo, et al.
Publicado: (2023)

Validation of a SARS-CoV-2 Surrogate Neutralization Test Detecting Neutralizing Antibodies against the Major Variants of Concern
por: Santos da Silva, Eveline, et al.
Publicado: (2023)

Relative Ratios of Human Seasonal Coronavirus Antibodies Predict the Efficiency of Cross-Neutralization of SARS-CoV-2 Spike Binding to ACE2
por: Galipeau, Yannick, et al.
Publicado: (2021)

Development of a Surrogate Neutralization Assay for Norovirus Vaccine Evaluation at the Cellular Level
por: Wang, Xiaoli, et al.
Publicado: (2018)

Evaluation of Cell-Based and Surrogate SARS-CoV-2 Neutralization Assays
por: Sholukh, Anton M., et al.
Publicado: (2021)

Considerations for the Feasibility of Neutralizing Antibodies as a Surrogate Endpoint for COVID-19 Vaccines
por: Liu, Jianyang, et al.
Publicado: (2022)

A simple protein-based surrogate neutralization assay for SARS-CoV-2
por: Abe, Kento T., et al.
Publicado: (2020)

Validation and Establishment of the SARS-CoV-2 Lentivirus Surrogate Neutralization Assay as a Prescreening Tool for the Plaque Reduction Neutralization Test
por: Merluza, John, et al.
Publicado: (2023)

A Recombinant Chimeric Cedar Virus-Based Surrogate Neutralization Assay Platform for Pathogenic Henipaviruses
por: Amaya, Moushimi, et al.
Publicado: (2023)

Humoral Responses and Serological Assays in SARS-CoV-2 Infections
por: Galipeau, Yannick, et al.
Publicado: (2020)

Continuous false positive results by SARS-CoV-2 rapid antigen testing: a case report
por: Galipeau, Yannick, et al.
Publicado: (2023)

A Multivariant Surrogate Neutralization Assay Identifies Variant-Specific Neutralizing Antibody Profiles in Primary SARS-CoV-2 Omicron Infection
por: Springer, David Niklas, et al.
Publicado: (2023)

An Assessment of Serological Assays for SARS-CoV-2 as Surrogates for Authentic Virus Neutralization
por: Wohlgemuth, Nicholas, et al.
Publicado: (2021)

Comparison of commercial SARS-CoV-2 surrogate neutralization assays with a full virus endpoint dilution neutralization test in two different cohorts
por: Adams, Ortwin, et al.
Publicado: (2022)

SARS-CoV-2 Seroprevalence in Those Utilizing Public Transportation or Working in the Transportation Industry: A Rapid Review
por: Heiskanen, Aliisa, et al.
Publicado: (2022)

The decay of long-lived neutral kaons into two neutral pions
por: Gaillard, Jean-Marc, et al.
Publicado: (1969)

Evaluating Humoral Immunity against SARS-CoV-2: Validation of a Plaque-Reduction Neutralization Test and a Multilaboratory Comparison of Conventional and Surrogate Neutralization Assays
por: Valcourt, Emelissa J., et al.
Publicado: (2021)

SARS-CoV-2 Neutralizing Responses in Various Populations, at the Time of SARS-CoV-2 Variant Virus Emergence: Evaluation of Two Surrogate Neutralization Assays in Front of Whole Virus Neutralization Test
por: Marot, Stephane, et al.
Publicado: (2022)

Attainment rate as a surrogate indicator of the intervertebral neutral zone length in lateral bending: an in vitro proof of concept study
por: Breen, Alexander C, et al.
Publicado: (2015)

Evaluation of a multi-species SARS-CoV-2 surrogate virus neutralization test
por: Embregts, Carmen W.E., et al.
Publicado: (2021)

Measurement of the decay of the long-lived neutral $K$ meson into two neutral pions
por: Gaillard, Jean-Marc, et al.
Publicado: (1967)

Novel Surrogate Neutralizing Assay Supports Parvovirus B19 Vaccine Development for Children with Sickle Cell Disease
por: Penkert, Rhiannon R., et al.
Publicado: (2021)

Antibody neutralization capacity after coronavirus disease 2019 vaccination in people with HIV in Canada
por: Costiniuk, Cecilia T., et al.
Publicado: (2023)

Evaluation of a surrogate virus neutralization test for high-throughput serosurveillance of SARS-CoV-2
por: Mariën, Joachim, et al.
Publicado: (2021)

Classification of neutral currents
por: Jarlskog, C
Publicado: (1975)

CXCL13 Neutralization Attenuates Neuropsychiatric Manifestations in Lupus-Prone Mice
por: Huang, Michelle W., et al.
Publicado: (2021)

Nanobodies that Neutralize HIV
por: Weiss, Robin A., et al.
Publicado: (2019)

Neutrality in the Metaorganism
por: Sieber, Michael, et al.
Publicado: (2019)

Performance of a Surrogate SARS-CoV-2-Neutralizing Antibody Assay in Natural Infection and Vaccination Samples
por: Chan, Kwok-Hung, et al.
Publicado: (2021)

Validation of a SARS-CoV-2 Surrogate Virus Neutralization Test in Recovered and Vaccinated Healthcare Workers
por: Mouna, Lina, et al.
Publicado: (2023)

Effect of vaccine dosing intervals on Omicron surrogate neutralization after three doses of BNT162b2
por: Prusinkiewicz, Martin A., et al.
Publicado: (2023)

Omicron BA.1/1.1 SARS-CoV-2 Infection among Vaccinated Canadian Adults
por: Brown, Patrick E., et al.
Publicado: (2022)

Evaluation of a SARS-CoV-2 Surrogate Virus Neutralization Test for Detection of Antibody in Human, Canine, Cat, and Hamster Sera
por: Perera, Ranawaka A. P. M., et al.
Publicado: (2021)

Correction for Valcourt et al., “Evaluating Humoral Immunity against SARS-CoV-2: Validation of a Plaque-Reduction Neutralization Test and a Multilaboratory Comparison of Conventional and Surrogate Neutralization Assays”
por: Valcourt, Emelissa J., et al.
Publicado: (2022)

Removal of variable domain N-linked glycosylation as a means to improve the homogeneity of HIV-1 broadly neutralizing antibodies
por: Chuang, Gwo-Yu, et al.
Publicado: (2020)

Neutralization of reovirus: the gene responsible for the neutralization antigen
Publicado: (1977)

Stochastic neutral drifts seem prevalent in driving human virome assembly: Neutral, near-neutral and non-neutral theoretic analyses
por: Ma, Zhanshan (Sam), et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ubshjoudvi77llb2oq079d7cp2